Cargando…

Natural prognosis of carbapenem-resistant Acinetobacter baumannii bacteremia in patients who did not receive appropriate antibiotic treatment: A retrospective multicenter study in Korea

Carbapenem-resistant Acinetobacter baumannii (CRAB) infection is a major issues in current era. The aim of study was to investigate the natural prognosis and prognostic factors associated with 28-day mortality in patients with CRAB bacteremia who were not receiving appropriate antibiotic treatment....

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Tark, Lee, Eun Jung, Park, Seong Yeon, Yu, Shi Nae, Lee, Yu Mi, Park, Ki-Ho, Park, Se Yoon, Jeon, Min Hyok, Choo, Eun Ju, Kim, Tae Hyong, Lee, Mi Suk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6221697/
https://www.ncbi.nlm.nih.gov/pubmed/30412128
http://dx.doi.org/10.1097/MD.0000000000012984
_version_ 1783369070950744064
author Kim, Tark
Lee, Eun Jung
Park, Seong Yeon
Yu, Shi Nae
Lee, Yu Mi
Park, Ki-Ho
Park, Se Yoon
Jeon, Min Hyok
Choo, Eun Ju
Kim, Tae Hyong
Lee, Mi Suk
author_facet Kim, Tark
Lee, Eun Jung
Park, Seong Yeon
Yu, Shi Nae
Lee, Yu Mi
Park, Ki-Ho
Park, Se Yoon
Jeon, Min Hyok
Choo, Eun Ju
Kim, Tae Hyong
Lee, Mi Suk
author_sort Kim, Tark
collection PubMed
description Carbapenem-resistant Acinetobacter baumannii (CRAB) infection is a major issues in current era. The aim of study was to investigate the natural prognosis and prognostic factors associated with 28-day mortality in patients with CRAB bacteremia who were not receiving appropriate antibiotic treatment. Adult patients with CRAB bacteremia were retrospectively identified between April 2012 and March 2015 at 5 tertiary hospitals in Republic of Korea. Patients who were transferred to another hospital within 28 days of onset of bacteremia and who receive appropriate antibiotics more than 48 hours were excluded. We investigated prognostic factors associated with 28-day mortality in patients with CRAB bacteremia without appropriate antibiotic treatment. Of enrolled 205 patients, 143 (69.8%) patients died within 28 days after blood culture. Of patients with 28-day mortality, 88.9% (127/143) of patients died within 5 days. Of 78 patients who survived more than 5 days, the 28-day mortality was 20.5% (16/78). Diabetes mellitus (adjusted odds ratio [aOR] 3.81, 95% confidence interval [95% CI] 1.19–12.20), immunocompromised (aOR 8.72, 95% CI 2.62–29.70), sequential organ failure assessment (SOFA) ≥ 10 (aOR 13.87, 95% CI 3.70–51.96), vasopressor use (aOR 7.03, 95% CI 1.79–27.60), and pneumonia (aOR 4.44, 95% CI 1.67–11.78) were found to be the factors independently associated with the 28-day mortality. The 28-day mortality in patients with CRAB bacteremia without appropriate treatment was high, although some patients could survive. Severity and underlying conditions were important prognostic factors in patients with CRAB bacteremia.
format Online
Article
Text
id pubmed-6221697
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-62216972018-12-04 Natural prognosis of carbapenem-resistant Acinetobacter baumannii bacteremia in patients who did not receive appropriate antibiotic treatment: A retrospective multicenter study in Korea Kim, Tark Lee, Eun Jung Park, Seong Yeon Yu, Shi Nae Lee, Yu Mi Park, Ki-Ho Park, Se Yoon Jeon, Min Hyok Choo, Eun Ju Kim, Tae Hyong Lee, Mi Suk Medicine (Baltimore) Research Article Carbapenem-resistant Acinetobacter baumannii (CRAB) infection is a major issues in current era. The aim of study was to investigate the natural prognosis and prognostic factors associated with 28-day mortality in patients with CRAB bacteremia who were not receiving appropriate antibiotic treatment. Adult patients with CRAB bacteremia were retrospectively identified between April 2012 and March 2015 at 5 tertiary hospitals in Republic of Korea. Patients who were transferred to another hospital within 28 days of onset of bacteremia and who receive appropriate antibiotics more than 48 hours were excluded. We investigated prognostic factors associated with 28-day mortality in patients with CRAB bacteremia without appropriate antibiotic treatment. Of enrolled 205 patients, 143 (69.8%) patients died within 28 days after blood culture. Of patients with 28-day mortality, 88.9% (127/143) of patients died within 5 days. Of 78 patients who survived more than 5 days, the 28-day mortality was 20.5% (16/78). Diabetes mellitus (adjusted odds ratio [aOR] 3.81, 95% confidence interval [95% CI] 1.19–12.20), immunocompromised (aOR 8.72, 95% CI 2.62–29.70), sequential organ failure assessment (SOFA) ≥ 10 (aOR 13.87, 95% CI 3.70–51.96), vasopressor use (aOR 7.03, 95% CI 1.79–27.60), and pneumonia (aOR 4.44, 95% CI 1.67–11.78) were found to be the factors independently associated with the 28-day mortality. The 28-day mortality in patients with CRAB bacteremia without appropriate treatment was high, although some patients could survive. Severity and underlying conditions were important prognostic factors in patients with CRAB bacteremia. Wolters Kluwer Health 2018-10-26 /pmc/articles/PMC6221697/ /pubmed/30412128 http://dx.doi.org/10.1097/MD.0000000000012984 Text en Copyright © 2018 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0
spellingShingle Research Article
Kim, Tark
Lee, Eun Jung
Park, Seong Yeon
Yu, Shi Nae
Lee, Yu Mi
Park, Ki-Ho
Park, Se Yoon
Jeon, Min Hyok
Choo, Eun Ju
Kim, Tae Hyong
Lee, Mi Suk
Natural prognosis of carbapenem-resistant Acinetobacter baumannii bacteremia in patients who did not receive appropriate antibiotic treatment: A retrospective multicenter study in Korea
title Natural prognosis of carbapenem-resistant Acinetobacter baumannii bacteremia in patients who did not receive appropriate antibiotic treatment: A retrospective multicenter study in Korea
title_full Natural prognosis of carbapenem-resistant Acinetobacter baumannii bacteremia in patients who did not receive appropriate antibiotic treatment: A retrospective multicenter study in Korea
title_fullStr Natural prognosis of carbapenem-resistant Acinetobacter baumannii bacteremia in patients who did not receive appropriate antibiotic treatment: A retrospective multicenter study in Korea
title_full_unstemmed Natural prognosis of carbapenem-resistant Acinetobacter baumannii bacteremia in patients who did not receive appropriate antibiotic treatment: A retrospective multicenter study in Korea
title_short Natural prognosis of carbapenem-resistant Acinetobacter baumannii bacteremia in patients who did not receive appropriate antibiotic treatment: A retrospective multicenter study in Korea
title_sort natural prognosis of carbapenem-resistant acinetobacter baumannii bacteremia in patients who did not receive appropriate antibiotic treatment: a retrospective multicenter study in korea
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6221697/
https://www.ncbi.nlm.nih.gov/pubmed/30412128
http://dx.doi.org/10.1097/MD.0000000000012984
work_keys_str_mv AT kimtark naturalprognosisofcarbapenemresistantacinetobacterbaumanniibacteremiainpatientswhodidnotreceiveappropriateantibiotictreatmentaretrospectivemulticenterstudyinkorea
AT leeeunjung naturalprognosisofcarbapenemresistantacinetobacterbaumanniibacteremiainpatientswhodidnotreceiveappropriateantibiotictreatmentaretrospectivemulticenterstudyinkorea
AT parkseongyeon naturalprognosisofcarbapenemresistantacinetobacterbaumanniibacteremiainpatientswhodidnotreceiveappropriateantibiotictreatmentaretrospectivemulticenterstudyinkorea
AT yushinae naturalprognosisofcarbapenemresistantacinetobacterbaumanniibacteremiainpatientswhodidnotreceiveappropriateantibiotictreatmentaretrospectivemulticenterstudyinkorea
AT leeyumi naturalprognosisofcarbapenemresistantacinetobacterbaumanniibacteremiainpatientswhodidnotreceiveappropriateantibiotictreatmentaretrospectivemulticenterstudyinkorea
AT parkkiho naturalprognosisofcarbapenemresistantacinetobacterbaumanniibacteremiainpatientswhodidnotreceiveappropriateantibiotictreatmentaretrospectivemulticenterstudyinkorea
AT parkseyoon naturalprognosisofcarbapenemresistantacinetobacterbaumanniibacteremiainpatientswhodidnotreceiveappropriateantibiotictreatmentaretrospectivemulticenterstudyinkorea
AT jeonminhyok naturalprognosisofcarbapenemresistantacinetobacterbaumanniibacteremiainpatientswhodidnotreceiveappropriateantibiotictreatmentaretrospectivemulticenterstudyinkorea
AT chooeunju naturalprognosisofcarbapenemresistantacinetobacterbaumanniibacteremiainpatientswhodidnotreceiveappropriateantibiotictreatmentaretrospectivemulticenterstudyinkorea
AT kimtaehyong naturalprognosisofcarbapenemresistantacinetobacterbaumanniibacteremiainpatientswhodidnotreceiveappropriateantibiotictreatmentaretrospectivemulticenterstudyinkorea
AT leemisuk naturalprognosisofcarbapenemresistantacinetobacterbaumanniibacteremiainpatientswhodidnotreceiveappropriateantibiotictreatmentaretrospectivemulticenterstudyinkorea